REMEDIUM LIFECARE Financial Statement Analysis
|
||
The Revenues of REMEDIUM LIFECARE have increased by 692.74% YoY .
The Earnings Per Share (EPS) of REMEDIUM LIFECARE has decreased by -78.43 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
REMEDIUM LIFECARE Last 5 Annual Financial Results
[BOM: 539561]
Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
---|---|---|---|---|---|
Revenues | ₹4,042 Cr | ₹510 Cr | ₹505 Cr | ₹90 Cr | ₹2.89 Cr |
Expenses | ₹4,008 Cr | ₹503 Cr | ₹503 Cr | ₹89 Cr | ₹2.50 Cr |
Operating Profit (Excl OI) | ₹34 Cr | ₹7.17 Cr | ₹1.82 Cr | ₹0.72 Cr | ₹0.39 Cr |
Other Income | ₹21 Cr | ₹0.83 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr |
Interest | ₹4.78 Cr | ₹0.45 Cr | ₹0.23 Cr | ₹0.02 Cr | ₹0.01 Cr |
Depreciation | ₹0.06 Cr | ₹0.15 Cr | ₹0.07 Cr | ₹0.06 Cr | ₹0.01 Cr |
Profit Before Tax | ₹50 Cr | ₹7.40 Cr | ₹1.53 Cr | ₹0.65 Cr | ₹0.38 Cr |
Profit After Tax | ₹33 Cr | ₹5.43 Cr | ₹1.08 Cr | ₹0.48 Cr | ₹0.28 Cr |
Earnings Per Share (Rs) | ₹3.25 | ₹15.07 | ₹2.99 | ₹1.33 | ₹0.77 |
PAT Margin (%) | 0.81 | 1.06 | 0.21 | 0.53 | 9.58 |
ROE(%) | 122.76 | 70.92 | 24.51 | 13.33 | 8.62 |
ROCE(%) | 99.51 | 102.54 | 18.16 | 7.39 | 11.16 |
Total Debt/Equity(x) | 1.34 | 0.00 | 0.00 | 2.72 | 0.11 |
Key Financials |
||
Market Cap | : | ₹ 115.5 Cr |
Revenue (TTM) | : | ₹ 222.5 Cr |
Net Profit(TTM) | : | ₹ 1.5 Cr |
EPS (TTM) | : | ₹ 0.0 |
P/E (TTM) | : | 75.5 |
Industry Peers & Returns | 1W | 1M | 1Y |
REMEDIUM LIFECARE | -16.6% | -22.9% | -89.6% |
ADANI ENTERPRISES | 4.5% | 14.7% | -13.8% |
REDINGTON | 6.3% | 10% | 43.5% |
MMTC | -4.3% | 41% | 8.8% |
HONASA CONSUMER | 3.3% | 31.2% | -23.1% |
LLOYDS ENTERPRISES | 13.6% | 48.2% | 122.4% |
ENTERO HEALTHCARE SOLUTIONS | 0.8% | -10.7% | 18.2% |
OPTIEMUS INFRACOM | -4.1% | 16.9% | 161.5% |
POLO QUEEN INDUSTRIAL & FINTECH | -1.7% | -2.9% | 35.5% |
REMEDIUM LIFECARE Revenues
[BOM: 539561]
Y-o-Y | 692.74 % |
5 Yr CAGR | 511.53 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹4,042 Cr | 692.74 | |
Mar2023 | ₹510 Cr | 1.00 | |
Mar2022 | ₹505 Cr | 460.67 | |
Mar2021 | ₹90 Cr | 3,015.36 | |
Mar2020 | ₹2.89 Cr | - |
REMEDIUM LIFECARE Operating Profit
[BOM: 539561]
Y-o-Y | 376.96 % |
5 Yr CAGR | 206.39 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹34 Cr | 376.96 | |
Mar2023 | ₹7.17 Cr | 294.99 | |
Mar2022 | ₹1.82 Cr | 151.04 | |
Mar2021 | ₹0.72 Cr | 86.34 | |
Mar2020 | ₹0.39 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -39.72 % |
5 Yr CAGR | -49.84 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | 0.85% | -39.72 | |
Mar2023 | 1.41% | 291.67 | |
Mar2022 | 0.36% | -55.00 | |
Mar2021 | 0.8% | -94.04 | |
Mar2020 | 13.43% | - |
REMEDIUM LIFECARE Profit After Tax
[BOM: 539561]
Y-o-Y | 503.21 % |
5 Yr CAGR | 229.70 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹33 Cr | 503.21 | |
Mar2023 | ₹5.43 Cr | 403.34 | |
Mar2022 | ₹1.08 Cr | 124.12 | |
Mar2021 | ₹0.48 Cr | 73.65 | |
Mar2020 | ₹0.28 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -23.58 % |
5 Yr CAGR | -46.08 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | 0.81 % | -23.58 | |
Mar2023 | 1.06 % | 404.76 | |
Mar2022 | 0.21 % | -60.38 | |
Mar2021 | 0.53 % | -94.47 | |
Mar2020 | 9.58 % | - |
REMEDIUM LIFECARE Earnings Per Share (EPS)
[BOM: 539561]
Y-o-Y | -78.43 % |
5 Yr CAGR | 43.33 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹3.25 | -78.43 | |
Mar2023 | ₹15 | 404.01 | |
Mar2022 | ₹2.99 | 124.81 | |
Mar2021 | ₹1.33 | 72.73 | |
Mar2020 | ₹0.77 | - |
REMEDIUM LIFECARE Return on Capital Employed (ROCE)
[BOM: 539561]
Y-o-Y | -2.95 % |
5 Yr CAGR | 72.80 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2024 | 99.51% | -2.95 | |
Mar2023 | 102.54% | 464.65 | |
Mar2022 | 18.16% | 145.74 | |
Mar2021 | 7.39% | -33.78 | |
Mar2020 | 11.16% | - |
REMEDIUM LIFECARE Share Price vs Sensex
Current Share Price | : | ₹1.3 |
Current MarketCap | : | ₹ 115.5 Cr |
Updated EOD on | : | Jun 09,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
REMEDIUM LIFECARE | -16.6% |
-22.9% |
-89.6% |
SENSEX | 1.3% |
2.6% |
7.8% |
REMEDIUM LIFECARE related INDICES
You may also like the below Video Courses
FAQ about REMEDIUM LIFECARE Financials
How the annual revenues of REMEDIUM LIFECARE have changed ?
The Revenues of REMEDIUM LIFECARE have increased by 692.74% YoY .
How the Earnings per Share (EPS) of REMEDIUM LIFECARE have changed?
The Earnings Per Share (EPS) of REMEDIUM LIFECARE has decreased by -78.43 % YoY .
Intrinsic Value of ADANI ENTERPRISES LTD Intrinsic Value of REDINGTON LTD Intrinsic Value of MMTC LTD Intrinsic Value of HONASA CONSUMER LTD Intrinsic Value of LLOYDS ENTERPRISES LTD |
ADANI ENTERPRISES LTD vs REDINGTON LTD vs MMTC LTD
HONASA CONSUMER LTD vs LLOYDS ENTERPRISES LTD vs